Gene Query: CLDN9

Dataset Description Geneva Score
EP400 is required for Max and MCPyV mediated gene activation 55.76
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 19.96
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 19.87
NR2F2 study 19.87
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 17.11
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 17.11
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 7.33
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 6.54
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 6.38
Defective structural RNA processing in relapsing-remitting multiple sclerosis 5.54
RNA-seq differential expression studies: more sequence, or more replication? 5.2
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 5.09
MCF-7 as a model for functional analysis of breast cancer risk variants 4.47
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 4.41
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 4.41
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 4.34
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 4.34
Total RNA sequencing of APC mutant and wt colonic organoids 4.3
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 4.19
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 3.89
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 3.81
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 3.67
BASP1 modifies the Tamoxifen response 3.49
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 3.24
snRNAs as regulators of alternative splicing 3.02
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 2.68
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 2.55
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 2.48
MYCL and EP400 are required for Max and MCPyV mediated gene activation 2.2
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 2.04
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 2.04
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 2.01
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 1.96
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 1.89
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 1.87
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 1.8
RNA-Seq and expression data from human adipose tissue 1.71
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 1.71
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 1.65
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 1.57
Gene expression profiling of papillary thyroid cancer from central and invasive regions 1.54
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 1.52
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 1.47
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 1.42
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 1.42
Noncoding regions are the main source of targetable tumor-specific antigens 1.41
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 1.38
RNAseq of cell lines with knocked in ESR1 mutations 1.37
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 1.33
Conservative alteration of chromosomal expression pattern across human solid tumor types 1.29
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 1.24
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 1.23
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 1.2
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 1.14
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 1.11
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 1.07
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 1.06
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 1.06
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 1.06
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 1.04
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 1.03
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 1.02
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 0.99
Discovering human diabetes-risk gene function with genetics and physiological assays 0.97
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 0.94
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 0.92
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 0.91
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 0.91
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 0.9
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 0.88
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.85
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 0.84
Silencing p300 in MCF7 cells to study expression and alternative splicing 0.84
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 0.82
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 0.81
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 0.79
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 0.79
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 0.77
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 0.77
Overexpression of NFIB and YBX1 in MCF-7 cells 0.77
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 0.76
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 0.76
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 0.73
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.72
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 0.72
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 0.67
Differential Gene Expression between MCF10A and MCF7 cells 0.67
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 0.66
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 0.63
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 0.62
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 0.61
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 0.61
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 0.61
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 0.6
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 0.59
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 0.57
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 0.55
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.55
Gene expression analysis of breast cancer cell-lines 0.54
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.54
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.54
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 0.49
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 0.49
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 0.46
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 0.45
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 0.44
RNA sequencing of human pancreatic cancer cell lines 0.44
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 0.44
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 0.43
H1609088 Human RNA-Sequencing 0.43
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 0.42
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 0.42
Interaction between mitoNEET and NAF-1 in cancer cells 0.4
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 0.39
Transcriptome analysis of human lung epithelial cells 0.39
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 0.38
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 0.37
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 0.36
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 0.36
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 0.35
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 0.35
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 0.35
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 0.35
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 0.34
Expression analysis of the TAF1 syndrome 0.33
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.32
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 0.32
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 0.32
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 0.32
PTHrP overexpression in MCF7 cells 0.31
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 0.31
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 0.31
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.3
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 0.3
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 0.29
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 0.29
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 0.28
Leucegene: ALL sequencing 0.27
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 0.26
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 0.25
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 0.25
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 0.24
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 0.23
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 0.23
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 0.23
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 0.23
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 0.22
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 0.22
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 0.22
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 0.21
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 0.21
Transcriptional dependencies in diffuse intrinsic pontine glioma 0.21
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 0.21
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 0.21
Preclinical model of obesity and ER-positive breast cancer 0.2
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.2
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 0.2
Dysregulated immune system networks in war veterans with PTSD 0.2
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 0.2
RNA Seq of Alagille liver biopsies 0.19
Alagille_Nodder 0.19
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 0.19
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 0.19
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 0.19
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 0.19
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 0.19
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 0.19
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 0.18
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 0.18
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.18
Effect of nuclear IL-33 on gene expression 0.18
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.18
Transcriptomic analyssis following EHMT1/2 inhibition 0.18
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 0.17
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 0.17
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 0.17
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 0.17
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 0.17
The effect of Abl kinases on non-small cell carcinoma global transcriptome 0.17
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 0.17
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 0.17
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 0.17
Differential Protein Occupancy Profiling of the mRNA Transcriptome 0.17
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 0.17
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.17
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 0.16
Human embryonic stem cells in E8 and AKIT culture medium 0.16
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 0.16
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 0.16
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.16
A radiolabeling-free, qPCR-based method for locus-specific pseudouridine detection 0.16
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 0.16
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.15
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 0.15
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 0.15
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 0.15
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 0.15
Transciptomic profiling of human fetal lung samples 0.15
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 0.14
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 0.14
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 0.14
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 0.14
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 0.14
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 0.14
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 0.14
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 0.14
Gene Expression Profiling of WT and KDM3A Knocked out Cell 0.14
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 0.14
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.14
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.14
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 0.13
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 0.13
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 0.13
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.13
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 0.13
ENCODE Cold Spring Harbor Labs Long RNA-seq 0.13
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 0.13
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 0.13
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 0.13
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 0.13
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.13
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 0.12
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.12
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 0.12
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 0.12
Expression profiling of MCF-7 cells with treatment of TCDD 0.12
Identifying the molecular mode of action of itraconazole in colorectal cancer 0.12
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 0.12
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 0.12
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 0.12
Non-coding regions are the main source of tumor-specific antigens [human] 0.12
Non-coding regions are the main source of tumor-specific antigens 0.12
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 0.12
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 0.12
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 0.12
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 0.11
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 0.11
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 0.11
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 0.11
RNA-Seq of Breast and Ovarian Cancer Cell Lines 0.11
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 0.11
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.11
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 0.1
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 0.1
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq Human] 0.1
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 0.1
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 0.1
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 0.1
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 0.1
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.1
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.1
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 0.1
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 0.1
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 0.1
Transcriptional responses of human insulinoma cells to acute cytokine exposure 0.1
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 0.09
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 0.09
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 0.09
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 0.09
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 0.09
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 0.09
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 0.09
HNRNPL and its RNA Targets in Prostate Cancer 0.09
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 0.09
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 0.09
RNA seq with AML (NB4) cells upon FTO inhibition 0.09
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 0.09
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 0.08
RNA-Sequencing of HepG2 cells treated with TGFBeta 0.08
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 0.08
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.08
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 0.08
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 0.08
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 0.08
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 0.08
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 0.08
Identification of a LIF-responsive replication-competent human β cell 0.08
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 0.08
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 0.08
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 0.07
Gene expression alterations of pancreatic intraepithlial neoplasia 0.07
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 0.07
Fusion discovery in breast cancer cell line 0.07
AR-independent prostate cancer is sustained through FGF signaling 0.07
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 0.07
Tpl-2 and MEK small molecule inhibitors 0.07
Tpl-2 small molecule project 0.07
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 0.07
Energy Metabolism during Anchorage-Independence 0.07
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 0.07
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 0.07
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 0.07
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 0.07
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 0.06
UV_24h_GRO-Seq 0.06
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 0.06
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 0.06
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 0.06
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 0.06
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.06
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.06
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 0.06
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 0.06
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 0.06
Functional Haploid Human Oocytes Generated from Polar Body Genomes 0.06
HEK293 Heat-shock experiment 0.06
Reprogrammed myeloid cell transcriptomes in NSCLC 0.06
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 0.06
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 0.06
NKX2.2 0.06
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 0.06
iPSC-Derived Cholangiocytes 0.06
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 0.06
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 0.06
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 0.06
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 0.06
Total RNA sequencing of WT intestinal orgaonids. 0.05
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 0.05
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 0.05
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 0.05
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 0.05
A549 cell transcriptome responses to infection with H7N9 influenza virus 0.05
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 0.05
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 0.05
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 0.05
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 0.05
Hepatic transcriptome of pediatric hepatoblastoma. 0.05
Differentiation enhances Zika virus infection in neuronal brain cells 0.05
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 0.05
The transcriptome effect of overexpressing EZH2 in MCF7 0.05
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 0.05
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 0.05
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 0.05
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 0.05
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.05
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.05
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 0.05
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.05
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 0.05
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 0.05
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 0.05
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 0.05
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 0.05
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.05
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 0.05
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 0.05
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.05
mRNA sequencing of oropharyngeal cancer cell lines 0.05
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 0.04
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 0.04
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 0.04
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 0.04
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 0.04
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 0.04
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.04
RNA-seq analysis and shRNA screen of breast cancer 0.04
RNA-seq analysis of breast cancer 0.04
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 0.04
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 0.04
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 0.04
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 0.04
Tyrosine Kinase Inhibitor Cardiotoxicity 0.04
Gene expression profile in breast cancer cell lines using RNA sequencing 0.04
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 0.04
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.04
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 0.04
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 0.04
Epigenome regulation during epidermal lineage commitment 0.04
RNAseq of Breast cancer PDX samples 0.04
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 0.04
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.04
DRB/GRO-Seq -/+ UV 0.04
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 0.04
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 0.04
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 0.04
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 0.04
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.04
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.04
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.04
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 0.04
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.04
Epigenome regulation during epidermal lineage commitment [RNA-seq] 0.03
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 0.03
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.03
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 0.03
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 0.03
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 0.03
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 0.03
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 0.03
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.03
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.03
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 0.03
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 0.03
Transposon-based construction of strand-specific RNA-seq libraries 0.03
Transcriptome analyses of human pancreatic islets and pseudoislets 0.03
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 0.03
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 0.03
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 0.03
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 0.03
Transcriptome of EBV-infected gastric cancer cell lines 0.03
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 0.03
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 0.03
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 0.03
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 0.03
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 0.03
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 0.03
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 0.03
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 0.03
Analyses of T-ALL (COG study) 0.02
RNA sequencing of T-ALL (COG study) 0.02
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.02
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 0.02
Genome-wide Analysis of Chromatin Interactions in Human Cells 0.02
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 0.02
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 0.02
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 0.02
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 0.02
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.02
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 0.02
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 0.02
U2AF1 mutations alter splice site recognition in hematological malignancies 0.02
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 0.02
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.02
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.02
RNA-seq of cancer cell lines treated with T-025 0.02
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 0.02
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 0.02
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 0.02
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 0.02
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 0.02
A map of gene expression in neutrophil-like cell lines 0.02
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 0.02
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 0.02
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 0.02
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.02
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 0.02
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 0.02
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.02
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.02
STX4 Over-Expression in Human islets 0.02
Characterization of the Merkel cell carcinoma miRNome 0.01
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 0.01
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 0.01
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.01
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.01
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 0.01
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 0.01
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.01
Interphase condensins regulate ligand-depedent enhancer activation 0.01
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.01
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 0.01
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 0.01
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 0.01
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 0.01
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 0.01
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.01
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 0.01
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.01
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 0.01
Exploring ILF2 regulatory genes by next-generation sequencing 0.01
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 0.01
Investigate A2M treatment on human prostate cancer xenograft in mice 0.01
Investigate A2M treatment on human prostate cancer and mouse liver 0.01
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 0.01
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 0.01
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.01
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 0.01
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 0.01
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.01
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 0.01
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 0.01
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 0.01
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 0.01
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.01
RNA-seq of SCLC PDX models treated with EP 0.01
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 0.01
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 0.01
Zone dependent distinctive gene expression profile of the normal human liver tissue 0.01
Cellular response to hepatitis E virus (HEV) infection 0.01
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 0.01
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 0.01
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.0
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 0.0
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 0.0
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 0.0
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.0
Multiple sclerosis and EAE 0.0
Human optic chiasm from healthy controls and multiple sclerosis patients 0.0
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 0.0
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.0
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 0.0
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.0
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 0.0
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.0
A single cell reference map for human blood and tissue T cell activation 0.0
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.0
RNA-Seq in neutrophils from Antiphospholipid Syndrome 0.0
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 0.0
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 0.0
Iron response of HepG2 cells 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation